With a market cap of $17.4 billion, Biogen Inc. (BIIB) is a global biotechnology leader focused on discovering, developing, ...

Biogen has made a further push into RNA ... RNA sequencing data to discover new drug targets and therapeutics. Cambridge, Massachusetts-based Envisagenics focuses on using AI to analyse errors ...

Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt – it has just filed a lawsuit seeking to block the deal. Specific details of the lawsuit are not yet available ...

The lawsuit, which was filed in federal court in Massachusetts accuses the government of cutting funds “as part of its pressure campaign” to force the university “to submit to the government ...

Philip Gotwals, Ph.D. and Steve Crouse bring strategic and operational experience in business development and global tools and technology “We’re delighted to welcome Phil and Steve to our ...

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined Pediarix (GlaxoSmithKline) 24 hr Manufacturer Diphtheria and ...

This house has witnessed a lot of history. Not only did it serve as General George Washington's headquarters during the Siege of Boston (considered the beginning stages of the Revolutionary War ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) ...

Healthcare & Pharmaceuticalscategory Britain to invest up to $767 mln in new health data research April 7, 2025 Healthcare & Pharmaceuticalscategory Novo Nordisk to invest $1.09 billion to boost ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.